Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Heiq Plc LSE:HEIQ London Ordinary Share GB00BN2CJ299 ORD GBP0.30
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.25 -0.71% 35.00 34.50 36.00 35.50 35.25 35.25 59,445 16:35:26
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 36.9 5.1 3.1 10.3 44

Heiq Share Discussion Threads

Showing 151 to 175 of 675 messages
Chat Pages: Latest  15  14  13  12  11  10  9  8  7  6  5  4  Older
DateSubjectAuthorDiscuss
28/1/2021
18:56
DB - I agree. It is so transparent isn't it? And I think it is because Carlo is taking advice from Arlington and Cenkos.

So the info in the TU contains no numbers and is vague. Why? Because then Cenkos adds value with their broker note. Then the share price tanks because of the PI confusion.

So Carlo asks broker what to do? Have you got any news we can release? is the answer. Great lets put out an RNS - (and this is done in the middle of the day as well which is poor)

What HEIQ should have done is release the TU a day earlier - on Monday morning. Then they can fully explain the situation at the Mello event on Monday evening. Then the PI understands the position.

Result - the share price would have gone down Monday but then recovered and the BOD could have been more open in explaining the situation on Monday night - meaning they looked much more credible and in control. Then - today's RNS is released at 7am and the share price moves forward. .

But all of this does not change my view that this company has great products and great prospects.

melody9999
28/1/2021
13:34
Just a bit of PR. They are probably smarting a bit from the reaction to their las RNS.

Nice recovery today. Am now in profit even including my terrible trade. Unfortunately drowning in a sea of red elsewhere, pretty much lost all this years gains

dr biotech
28/1/2021
11:38
Good news on product on RNS
2bluelynn
28/1/2021
08:17
Great if this price has stabilised now .
2bluelynn
27/1/2021
11:46
It's a pity HeiQ was unable to provide a more comprehensive update, but according to Investor's Champion this this still looks an exciting offering, albeit one now carrying a rich rating which it will need to justify.
energeticbacker
27/1/2021
10:01
Shavian,
you've been spending too much time on the VRS board!

see slides 31-33 in htTp://brubeckskiclub.pl/wp-content/uploads/2020/09/20200414_HeiQ-Viroblock.pdf and slide 11 in htTps://heiq.com/wp-content/uploads/2020/12/2020.12_HeiQ-company-presentation_Investors.pdf

davemac3
27/1/2021
10:00
Drop of 33% for an “in line” trading statement seems harsh. Long term use if these coatings in airlines/trains etc must be a significant target. I have bought in - will have to remember the spread bet cost in my calculations...

—-

You can get fart proof pants already. I saw an ad for them once, no idea if/how they work. Given the amount of flatulence on these boards I’m sure someone can offer more insight.

dr biotech
27/1/2021
09:50
Flatulence?
alex1621
27/1/2021
09:38
Having lucked in with an original entry price of 126p, I'm excited at the chance to double up at a reasonable price, which it now looks to be approaching. As others have said this one is bound to be volatile, so adding on the dips is the best plan for LTH.Latest COVID news confirms that the market for effective masks will continue to be massive for a much longer time than at first thought. One point is that HEIQ must look to upgrade its masks to FFP2/KN95 spec. The current medical-grade masks Type IIR are as much use as a chocolate teapot to defend against incoming Virus although they can protect others against outgoing virus; however HEIQ's should be better than standard because of the patented Virobloc impregnation but they are not certified to WHO Standard.
shavian
27/1/2021
09:13
240p to 150p . Battered. Brutal
john09
27/1/2021
09:10
From post 146 "Millions of people die from harmful indoor air each year...."

What's that all about then?

impvesta
27/1/2021
09:09
MMs must be filling a large sell order in the background
melody9999
27/1/2021
08:58
Admittedly taken a small starter position here.
tole
27/1/2021
08:46
Not my greatest effort tbh.
dr biotech
27/1/2021
08:42
That's a very tight stop on just a 2 point spread !
masurenguy
27/1/2021
08:38
In at 166 £40pp. Spread bet for me, hoping for short term bounce rather than long term hold at the moment. Stop loss 158.
dr biotech
27/1/2021
08:27
Tech firm that's fit for a Queen
Heiq

Gloves have soared in popularity this past year, as men and women alike have looked for extra protection against coronavirus.

The Queen, however, has been one step ahead. Her Majesty has been wearing beautiful gloves for years. And one of her favourite designers, Cornelia James, is now making them with a special antiviral compound, designed to break down viruses and stop them from spreading.

Gloves are on: One of Her Majesty’s favourite designers makes gloves using HeiQ’s antiviral technology +4
Gloves are on: One of Her Majesty’s favourite designers makes gloves using HeiQ’s antiviral technology

The technology was pioneered by HeiQ (pronounced High Q), a Zurich-based group that joined the London stock market just last month.

Founded by two engineers in 2005, HeiQ specialises in devising ways to make materials work better. The antiviral technology has been used to make souped-up masks, for instance, used by hospital staff and careful consumers around the world.

Other HeiQ compounds are used to cool down clothes or warm them up, while another technology helps to reduce the environmental impact of dyeing textiles.

There is even a product that can be incorporated into curtains, carpets and furniture to purify the air around them. Millions of people die from harmful indoor air each year so the technology has enormous potential.

HeiQ is not just a blue-sky tech firm. The Queen is almost certainly its most famous customer but founders Carlo Centonze and Murray Height work with a host of multinational firms, including Zara, Primark, swimwear specialist Speedo and Ikea, which has adopted the clear air technology in one of its curtain designs.

The group reports in dollars, as most of its transactions are denominated in the US currency. This year, revenues of $43million (£32million) are expected with profits of around $8million. In the next few years, however, Centonze and Height expect to take revenues to $300million – and supporters are confident they can do it.

Midas verdict: HeiQ is a young, ambitious technology business so the shares are not for the cautious investor. But the group has already proved that it can create products which customers want and need and the shares, at £1.81, could go far.

Traded on: Main market / Ticker: HEIQ / Contact: heiq.com or 00 41 56 250 6850.

chateaumusar
27/1/2021
08:26
Looks so awesome for a trade from here
chateaumusar
27/1/2021
08:13
ok cheers melody, but hes only held from dec
chateaumusar
27/1/2021
08:12
unlikely chateau - he is a long term holder
melody9999
27/1/2021
08:10
Has Leon from Mellow sold out
chateaumusar
26/1/2021
15:26
Once you get over the shock of seeing it drop like a stone, its a great opportunity.
Bought more today myself too.

bigwig
26/1/2021
14:13
miti - Cenkos seem to have been quite close to the real story here - credit where it is due. Their earlier note P39 says:

In the short-term we forecast specific HeiQ Viroblock revenues of $13.5m in 2020E
and $11.5m in 2021E, with the YoY decline reflecting the significant demand HeiQ fulfilled during the peak of the COVID-19 pandemic during Q2/20. These forecasts do not include sales of consumer products treated with HeiQ Viroblock or any potential revenues from licensing and royalties.

As noted above, the antimicrobial textile market is expected to grow at a mid-single digit CAGR over the near- to mid-term, becoming a low double digit billion-dollar market by the mid-2020s. As such, at the current sales level, HeiQ’s market share is less than 1% of the total current antimicrobial textile market

Bit surprised Cenkos do not see larger growth than that. And from your comment the CEO is being more bullish ....but in any case my thinking is H2 20 is the low point for Viroblock sales - mainly because everyone bought masks at good prices (for HEIQ) in H1 and had stocks into H2....Onward and upward from here.

melody9999
26/1/2021
14:00
Wouldn't mind a gap fill to 117p first gap
chateaumusar
26/1/2021
13:55
Gaps on a chart tend to always get filled at some point so prob best to get filled now. Can then move up .
2bluelynn
Chat Pages: Latest  15  14  13  12  11  10  9  8  7  6  5  4  Older
Your Recent History
LSE
HEIQ
Heiq
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230127 03:48:12